MC

606.5

-0.7%↓

SANES

5.999

+0.02%↑

BNP

73.7

-0.19%↓

ALV

347.9

+0.43%↑

BBVA

12.795

-0.78%↓

MC

606.5

-0.7%↓

SANES

5.999

+0.02%↑

BNP

73.7

-0.19%↓

ALV

347.9

+0.43%↑

BBVA

12.795

-0.78%↓

MC

606.5

-0.7%↓

SANES

5.999

+0.02%↑

BNP

73.7

-0.19%↓

ALV

347.9

+0.43%↑

BBVA

12.795

-0.78%↓

MC

606.5

-0.7%↓

SANES

5.999

+0.02%↑

BNP

73.7

-0.19%↓

ALV

347.9

+0.43%↑

BBVA

12.795

-0.78%↓

MC

606.5

-0.7%↓

SANES

5.999

+0.02%↑

BNP

73.7

-0.19%↓

ALV

347.9

+0.43%↑

BBVA

12.795

-0.78%↓

Search

AB Science SA

Closed

1.298 -3.42

Overview

Share price change

24h

Current

Min

1.22

Max

1.384

Key metrics

By Trading Economics

Income

-4.5M

Sales

560K

Profit margin

-798.036

Employees

40

EBITDA

-4.6M

Dividends

By Dow Jones

Next Earnings

29 Apr 2025

Market Stats

By TradingEconomics

Market Cap

95M

Previous open

4.72

Previous close

1.298

Technical Score

By Trading Central

Confidence

Weak Bullish Evidence

AB Science SA Chart

Past performance is not a reliable indicator of future results.

Related News

12 Mar 2025, 23:42 UTC

Hot Stocks

Stocks to Watch: Intel, Adobe, Tilly's, SentinelOne

12 Mar 2025, 22:48 UTC

Earnings

Algoma Steel Warns of Effects of Tariffs on Operations

12 Mar 2025, 20:45 UTC

Earnings

Adobe Posts Higher Profit, Revenue in 1Q

12 Mar 2025, 23:52 UTC

Top News
Earnings

Adobe Stock Slides Despite Earnings Beat. The CFO Is Confident About AI. -- Barrons.com

12 Mar 2025, 23:51 UTC

Market Talk

Global Equities Roundup: Market Talk

12 Mar 2025, 23:51 UTC

Market Talk

Nikkei May Rise as Concerns About U.S. Inflation Ebb -- Market Talk

12 Mar 2025, 23:49 UTC

Market Talk

Gold Edges Higher as Global Trade War Prospects Grow -- Market Talk

12 Mar 2025, 23:12 UTC

Earnings

Longfor Group 2023 Net Profit Was CNY12.85B >0960.HK

12 Mar 2025, 23:12 UTC

Earnings

Longfor Group: Decline in Revenue From Property Development Hurt Results >0960.HK

12 Mar 2025, 23:11 UTC

Earnings

Longfor Group Expects 2024 Net Profit to Decline by Around 20% on Year >0960.HK

12 Mar 2025, 22:54 UTC

Market Talk

Market Talk Roundup: Latest on U.S. Politics

12 Mar 2025, 22:53 UTC

Market Talk

Algoma Steel Says Tariffs Will Hurt Finances, Operations -- Market Talk

12 Mar 2025, 22:52 UTC

Market Talk

Intel's New CEO Tan Faces Decisions Regarding Company Structure, AI Strategy -- Market Talk

12 Mar 2025, 22:03 UTC

Market Talk

Alkane's Boda Project Gains Luster as Gold Prices Rise -- Market Talk

12 Mar 2025, 21:57 UTC

Market Talk

Bank of Canada Officials Did Discuss Leaving Policy Rate Unchanged -- Market Talk

12 Mar 2025, 21:31 UTC

Market Talk

Intel's Interim Co-CEOs Will Return to Prior Roles -- Market Talk

12 Mar 2025, 21:27 UTC

Top News

Intel Names Lip-Bu Tan as Chief Executive Officer -- 3rd Update

12 Mar 2025, 21:26 UTC

Market Talk

Intel CEO Sees 'Significant Opportunities' to Remake Business -- Market Talk

12 Mar 2025, 21:17 UTC

Market Talk

Global Equities Roundup: Market Talk

12 Mar 2025, 21:17 UTC

Market Talk

Intel Names Former Board Member Tan as Permanent CEO -- Market Talk

12 Mar 2025, 21:15 UTC

Top News

Senate GOP's Tax-Cut Wishlist Heads North of $5 Trillion -- WSJ

12 Mar 2025, 20:50 UTC

Top News

Walmart Gets an Earful From China Over Response to Trump Tariffs -- 2nd Update

12 Mar 2025, 20:50 UTC

Top News

Intel Names Lip-Bu Tan as Chief Executive Officer -- 2nd Update

12 Mar 2025, 20:50 UTC

Market Talk

Financial Services Roundup: Market Talk

12 Mar 2025, 20:50 UTC

Market Talk

Health Care Roundup: Market Talk

12 Mar 2025, 20:45 UTC

Top News

Intel Names Lip-Bu Tan as Chief Executive Officer -- Update

12 Mar 2025, 20:43 UTC

Top News

The Latest Overhaul of Starbucks -- by the Numbers -- Update

12 Mar 2025, 20:33 UTC

Acquisitions, Mergers, Takeovers

Murphy Oil: Reaffirming 2025 Cap Expenditure Guidance Range of $1.135B to $1.285B, With 1Q CAPEX Reaffirmed at $425M >MUR

12 Mar 2025, 20:33 UTC

Acquisitions, Mergers, Takeovers

Murphy Oil: Subsidiary Signed a Purchase and Sale Agreement to Acquire the BW Pioneer Floating Production Storage and Offloading Vessel From BW Offshore >MUR

12 Mar 2025, 20:33 UTC

Acquisitions, Mergers, Takeovers

Murphy Oil: Gross Purchase Price Is $125M, Includes Initial Approximate $100M Payment Upon Delivery by the End 1Q >MUR

Peer Comparison

Price change

AB Science SA Forecast

Technical Score

By Trading Central

1.376 / 1.414Support & Resistance

Short Term

Weak Bullish Evidence

Intermediate Term

Bullish Evidence

Long Term

Strong Bullish Evidence

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About AB Science SA

AB Science S.A., a clinical-stage company, designs and develops novel drugs to various diseases with high unmet medical needs for inflammatory diseases, pathologies affecting peripheral and central nervous system, and cancers in France. The company's lead compound is the masitinib, a tyrosine kinase inhibitor which is in Phase III clinical trials for the treatment of amyotrophic lateral sclerosis, indolent systemic mastocytosis, severe asthma, progressive forms of multiple sclerosis, first line pancreatic cancer with pain, alzheimer's disease, and metastatic castrate-resistant prostate cancer, as well as in Phase II clinical trial to treat Covid-19. It also developing AB8939, a microtubule destabiliser for acute myeloid leukemia. The company markets its masitinib under the Masivet brand in Europe. AB Science S.A. was incorporated in 2001 and is headquartered in Paris, France.